Business Description
DaVita Inc
NAICS : 621492
SIC : 8092
ISIN : US23918K1088
Total Employee Number:
78,000Compare
Compare
Traded in other countries / regions
DVA.USA0I7E.UKTRL.GermanyDVA.Mexico1DVA.ItalyDVAI34.Brazil Index Membership
S&P 500Russell 1000Russell 3000 IPO Date
1995-10-31Description
DaVita is one of the largest providers of dialysis services in the United States, boasting a market share of about 35%. The firm operates over 3,200 facilities worldwide, mostly in the US, and treats about 300,000 patients annually. Government payers dominate US dialysis reimbursement. DaVita receives about two-thirds of US sales at government (primarily Medicare) reimbursement rates, with the remainder coming from commercial insurers. While commercial insurers represent only about 10% of US patients treated, they represent nearly all of the profits generated by DaVita in the US dialysis business.
Financial Strength
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.05 | |||||
Equity-to-Asset | -0.04 | |||||
Debt-to-Equity | -17.52 | |||||
Debt-to-EBITDA | 4.84 | |||||
Interest Coverage | 3.52 | |||||
Piotroski F-Score | 6/9 | |||||
Altman Z-Score | 1.68 | |||||
Beneish M-Score | -2.8 | |||||
WACC vs ROIC | ||||||
Growth Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 14.1 | |||||
3-Year EBITDA Growth Rate | 17.5 | |||||
3-Year EPS without NRI Growth Rate | 17.8 | |||||
3-Year FCF Growth Rate | 19.9 | |||||
Future 3-5Y EPS without NRI Growth Rate Estimate Industry Rank | 21.48 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 2.95 |
Momentum Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 36.68 | |||||
9-Day RSI | 32.63 | |||||
14-Day RSI | 32.02 | |||||
3-1 Month Momentum % | 26.49 | |||||
6-1 Month Momentum % | 53.61 | |||||
12-1 Month Momentum % | 74.28 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 1.47 | |||||
Quick Ratio | 1.41 | |||||
Cash Ratio | 0.24 | |||||
Days Inventory | 5.69 | |||||
Days Sales Outstanding | 63.13 | |||||
Days Payable | 25.83 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | 8.8 | |||||
Shareholder Yield % | 7.48 |
Profitability Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 32.36 | |||||
Operating Margin % | 14.93 | |||||
Net Margin % | 6.05 | |||||
EBITDA Margin % | 19.79 | |||||
FCF Margin % | 11.49 | |||||
OCF Margin % | 15.65 | |||||
ROE % | Neg. Equity | |||||
ROA % | 4.83 | |||||
ROIC % | 10.37 | |||||
3-Year ROIIC % | -149.17 | |||||
ROC (Joel Greenblatt) % | 37.01 | |||||
ROCE % | 14.14 | |||||
Years of Profitability over Past 10-Year | 10 | |||||
Moat Score | 7 | |||||
Tariff Resilience Score | 8 |
GF Value Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 14.41 | |||||
Forward PE Ratio | 10.33 | |||||
PE Ratio without NRI | 13.74 | |||||
Shiller PE Ratio | 22.05 | |||||
Price-to-Owner-Earnings | 10.19 | |||||
PEG Ratio | 1.05 | |||||
PS Ratio | 0.88 | |||||
Price-to-Free-Cash-Flow | 7.78 | |||||
Price-to-Operating-Cash-Flow | 5.65 | |||||
EV-to-EBIT | 12.51 | |||||
EV-to-Forward-EBIT | 11.15 | |||||
EV-to-EBITDA | 9.31 | |||||
EV-to-Forward-EBITDA | 8.24 | |||||
EV-to-Revenue | 1.84 | |||||
EV-to-Forward-Revenue | 1.65 | |||||
EV-to-FCF | 16.03 | |||||
Price-to-GF-Value | 0.9 | |||||
Price-to-Projected-FCF | 0.63 | |||||
Price-to-DCF (Earnings Based) | 0.76 | |||||
Price-to-DCF (FCF Based) | 0.31 | |||||
Price-to-Median-PS-Value | 0.87 | |||||
Price-to-Peter-Lynch-Fair-Value | 0.99 | |||||
Earnings Yield (Greenblatt) % | 7.99 | |||||
FCF Yield % | 14.32 | |||||
Forward Rate of Return (Yacktman) % | 22.58 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NYSE:DVA
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
DaVita Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 14,009.646 | ||
| EPS (TTM) ($) | 12.22 | ||
| Beta | 1.3028 | ||
| 3-Year Sharpe Ratio | 0.74 | ||
| 3-Year Sortino Ratio | 1.6 | ||
| Volatility % | 61.73 | ||
| 14-Day RSI | 32.02 | ||
| 14-Day ATR ($) | 5.870091 | ||
| 20-Day SMA ($) | 179.1445 | ||
| 12-1 Month Momentum % | 74.28 | ||
| 52-Week Range ($) | 101 - 247.49 | ||
| Shares Outstanding (Mil) | 63.8 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 6 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
DaVita Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
DaVita Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| Annual report for 2026 | 2027-02-11 | In 162 days | ||
| Fourth quarter earnings conference call for 2026 | 2027-02-02 17:00 | In 154 days | ||
| Fourth quarter earnings results for 2026 | 2027-02-02 | In 153 days | ||
| Third quarter earnings conference call for 2026 | 2026-10-29 17:00 | In 58 days | ||
| Third quarter earnings results for 2026 | 2026-10-29 | In 57 days | ||
| Second quarter earnings conference call for 2026 | 2026-08-04 17:00 | 233.68 (-4.62%) | ||
| Second quarter earnings results for 2026 | 2026-08-04 | 233.68 (-4.62%) | ||
| General meeting for 2026 | 2026-06-04 10:00 | 195.03 (+3.47%) | ||
| Guidance call for 2026 | 2026-05-12 17:20 | 198.93 (-0.95%) | ||
| First quarter earnings conference call for 2026 | 2026-05-05 17:00 | 154.08 (+1.59%) |
Show
Entries
DaVita Inc Frequently Asked Questions
What is DaVita Inc(DVA)'s stock price today?
The current price of DVA is $176.14. The 52 week high of DVA is $247.49 and 52 week low is $101.00.
When is next earnings date of DaVita Inc(DVA)?
The next earnings date of DaVita Inc(DVA) is 2026-10-29 Est..
Does DaVita Inc(DVA) pay dividends? If so, how much?
DaVita Inc(DVA) does not pay dividend.
Guru Commentaries on NYSE:DVA
Moon Capital Management
Bearish
2026 Q2
What the manager wrote
During the second quarter, we exited our position in the kidney dialysis services company DaVita. While DaVita remains an exceptional operator with a well-established competitive advantage, we concluded that the future opportunity had become less attractive following the significant appreciation in the stock. After decades of expansion, total dialysis treatment volume has been roughly flat for the past six years. The company has also acknowledged that reimbursement growth continues to lag inflationary pressures affecting its cost structure. We believe future returns will depend primarily on business growth, a more difficult path given the company’s underlying volume trend.
Press Release
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers